Immune Monitoring Core
Immune Monitoring Core
批准号:
10197008
负责人:
Leo Luznik
金额:
$35.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-21 至 2024-04-30
关键词:
Adverse eventAllogenicAreaAutologousBehaviorBiological AssayBiological Specimen BanksBloodBone Marrow TransplantationCellsClinical TrialsClonalityCollaborationsComputing MethodologiesConduct Clinical TrialsDatabasesDetectionDiseaseDissectionEffectivenessEnrollmentEquilibriumEragrostisExpression ProfilingFlow CytometryFrequenciesFutureGalactose Binding LectinGene Expression ProfileGenesGoalsHumanHuman PapillomavirusImage AnalysisImmuneImmune responseImmune systemImmunizationImmunoassayImmunologic MonitoringImmunologicsImmunologyImmunology procedureImmunosuppressionImmunotherapeutic agentImmunotherapyIndividualInfrastructureLigandsMHC Class I GenesMeasuresModalityMolecularPatientsProceduresQuality ControlRNARegulatory T-LymphocyteResearchResearch PersonnelResearch Project GrantsResourcesSignaling MoleculeSpecimenStainsStandardizationSystemT-LymphocyteT-cell receptor repertoireTechniquesTechnologyTestingTherapeuticTimeTissuesTumor Tissueanti-PD1 therapyanti-tumor immune responseantigen-specific T cellsbasecancer stem cellcell typecytokinedesigndigital imaginghuman diseaseimmune functionimmune reconstitutionimmunogenicimmunoregulationin vivoinsightinterestlaser capture microdissectionmultidimensional datanovelpatient responseperipheral bloodprogrammed cell death ligand 1responders and non-respondersresponsetargeted treatmenttherapeutic effectivenesstumor
中文摘要
免疫监测核心
项目摘要
基于免疫的疗法在增强自体移植后的抗肿瘤免疫应答中的应用
同种异体血液或骨髓移植(BMT)在过去几年中显著增加。
BMT、GVHD和移植后免疫抑制后免疫系统的重建可能会改变
任何免疫方法。需要仔细评估和监测免疫反应,
背景变得越来越明显。人类免疫学核心(Core C)的主要目标是
作为评估免疫功能的免疫监测的集中资源,
参加临床试验的患者。虽然正在评估的治疗方式多种多样,
大多数领域在免疫应答的分析和表征方面有很大的重叠。种类繁多
计数和表征T细胞的技术,评估其体外功能行为,评估多样性,
的响应,表征他们的基因表达签名,以及可视化多维数据使用
新的计算方法可用于本P01中的研究项目。的具体目标
免疫学核心(核心C)是:1)提供复杂的免疫监测测定,
患者对免疫疗法的反应。作为这一目标的一部分,人类免疫学
核心(核心C)将为所有研究人员提供指导和专业知识,以优化整合新的高-
由Core C开发和使用的质量相关测定用于免疫机制的解剖,
建立免疫学试验的标准操作规程和质量控制,
项目调查员并实施技术支持; 2)进行分析并表征
用于特定临床试验的免疫反应。作为这项工作的一部分,免疫监测核心将服务于
作为生物样本的储存库,维护指定临床试验的数据库,并进行深入的
与在项目1-4下进行的指定临床试验相关的机制分析。
英文摘要
Immune Monitoring Core
Project Summary
The application of immune-based therapies to augment the anti-tumor immune responses following autologous
and allogeneic blood or marrow transplantation (BMT) has dramatically increase over the past several years.
Reconstitution of the immune system following BMT, GVHD, and post-grafting immunosuppression may modify
any immunotherapeutic approach. The need to carefully evaluate, and monitor the immune response in this
setting has become increasingly apparent. The principle objective of the Human Immunology Core (Core C) is
to serve as the centralized resource for the assessment of immunological monitoring of immune function in
patients enrolled on the clinical trials. While there is great diversity in the therapeutic modalities being evaluated,
most areas strongly overlap with regard to analysis and characterization of the immune response. A wide-variety
of techniques that enumerate and characterize T cells, assess their functional behavior ex vivo, evaluate diversity
of the response, characterize their gene expression signature as well as visualize multidimensional data using
novel computational methods are available to the research projects within this P01. The specific aims of the
Immunology Core (Core C) are to: 1) Provide sophisticated immune monitoring assays for measuring
patients’ responses to immune therapies across projects. As a part of this aim, the Human Immunology
core (Core C) will provide guidance and expertise to all investigators for the optimal integration of new high-
quality correlative assays developed and utilized by the Core C for dissection of immunologic mechanisms,
establish standard operating procedures and quality control for immunological assays that will be performed by
the project investigators and implement the technical support; 2) Conduct assays and characterize the
immune responses for specific clinical trials. As a part of this effort, the Immune Monitoring Core will serve
as a repository for biospecimens, maintain the database for designated clinical trials and conduct in-depth
mechanistic analysis associated with designated clinical trials conducted under Projects 1-4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Marrow-Infiltrating Lymphocytes
-
批准号:10197002
-
项目类别:
-
资助金额:$24.39万
-
财政年份:2019
-
负责人:Leo Luznik
-
依托单位:
Marrow-Infiltrating Lymphocytes
-
批准号:10671622
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2019
-
负责人:Leo Luznik
-
依托单位:
Immune Monitoring Core
-
批准号:10671632
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2019
-
负责人:Leo Luznik
-
依托单位:
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
-
批准号:8392233
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2011
-
负责人:Leo Luznik
-
依托单位:
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
-
批准号:8766561
-
项目类别:
-
资助金额:$41.48万
-
财政年份:2011
-
负责人:Leo Luznik
-
依托单位:
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
-
批准号:8582562
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2011
-
负责人:Leo Luznik
-
依托单位:
MECHANISMS OF GVHD PREVENTION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
-
批准号:8269451
-
项目类别:
-
资助金额:$43.58万
-
财政年份:2011
-
负责人:Leo Luznik
-
依托单位:
Augmenting Antitumor Immunity after Allografting
-
批准号:7466112
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2008
-
负责人:Leo Luznik
-
依托单位:
Augmenting Antitumor Immunity after Allografting
-
批准号:8010394
-
项目类别:
-
资助金额:$28.17万
-
财政年份:2008
-
负责人:Leo Luznik
-
依托单位:
Augmenting Antitumor Immunity after Allografting
-
批准号:8208131
-
项目类别:
-
资助金额:$29.55万
-
财政年份:2008
-
负责人:Leo Luznik
-
依托单位:
Augmenting Antitumor Immunity after Allografting
-
批准号:7575273
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2008
-
负责人:Leo Luznik
-
依托单位:
Augmenting Antitumor Immunity after Allografting
-
批准号:7765518
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2008
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:6233511
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:6514865
-
项目类别:
-
资助金额:$7.98万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:6633920
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:7005432
-
项目类别:
-
资助金额:$5.7万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:6838809
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
TUMOR VACCINES AFTER NON MYELOABLATIVE ALLOGRAFTING
-
批准号:6686393
-
项目类别:
-
资助金额:$13.68万
-
财政年份:2001
-
负责人:Leo Luznik
-
依托单位:
海外基金